Related Experiment Videos
Accelerated partial breast irradiation: technically feasible but who will benefit?
1Royal Marsden Hospital and Institute of Cancer Research, London, UK. Gillian.ross@rmh.nhs.uk
Breast Cancer Research : BCR
|July 1, 2005
Summary
Partial breast irradiation may safely reduce side effects in breast cancer patients. This approach targets only the tumor bed, unlike whole breast irradiation, and is being evaluated using various techniques.
Area of Science:
- Oncology
- Radiotherapy
- Surgical Oncology
Background:
- Modern breast cancer radiotherapy focuses on improving cure rates while minimizing long-term side effects like pain, cosmetic issues, and cardiac toxicity.
- Advances in breast cancer screening detect cancers earlier, potentially allowing for more localized radiation treatment after lumpectomy.
Purpose of the Study:
- To evaluate the safety and efficacy of partial breast irradiation (PBI) as an alternative to standard whole breast irradiation (WBI).
- To explore different technical approaches for delivering PBI in clinical trials.
Main Methods:
- Phase III studies are comparing various PBI techniques against standard WBI.
- Investigated methods include intra-operative single doses, accelerated hypofractionated brachytherapy, and linear accelerator (LINAC)-based 3D external beam therapy.
Main Results:
- Ongoing phase III studies are evaluating the outcomes of different partial breast irradiation techniques.
- Results will determine if PBI offers comparable efficacy with reduced toxicity compared to whole breast irradiation.
Conclusions:
- Partial breast irradiation is a promising strategy to reduce treatment-related toxicity in early-stage breast cancer.
- Further results from ongoing trials are necessary to establish PBI as a standard of care.